Common Stock, Shares, Issued of ORAMED PHARMACEUTICALS INC. from 31 Aug 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
ORAMED PHARMACEUTICALS INC. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Aug 2011 to 30 Sep 2025.
  • ORAMED PHARMACEUTICALS INC. Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 40,838,226, a 1.6% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

ORAMED PHARMACEUTICALS INC. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 40,838,226 +628,651 +1.6% 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 40,845,087 +216,163 +0.53% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 40,850,455 +331,295 +0.82% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 39,919,545 -419,434 -1% 31 Dec 2024 10-Q 13 Nov 2025 2025 Q3
Q3 2024 40,209,575 -73,113 -0.18% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 40,628,924 +409,528 +1% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 40,519,160 +549,181 +1.4% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 40,338,979 +775,091 +2% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 40,282,688 +1,169,452 +3% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 40,219,396 +1,655,380 +4.3% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 39,969,979 +1,405,963 +3.6% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 39,563,888 +1,405,096 +3.7% 31 Dec 2022 10-K 06 Mar 2024 2023 FY
Q3 2022 39,113,236 +3,819,347 +11% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 38,564,016 +8,040,594 +26% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 38,564,016 +10,274,424 +36% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 38,158,792 +14,348,262 +60% 31 Dec 2021 10-K 06 Mar 2023 2022 FY
Q3 2021 35,293,889 +11,618,359 +49% 31 Aug 2021 10-QT 30 Mar 2022 2021 Q2
Q2 2021 30,523,422 +7,246,383 +31% 31 May 2021 10-Q 14 Jul 2021 2021 Q3
Q1 2021 28,289,592 +5,195,614 +22% 28 Feb 2021 10-Q 13 Apr 2021 2021 Q2
Q4 2020 23,810,530 +6,409,918 +37% 30 Nov 2020 10-Q 14 Jan 2021 2021 Q1
Q3 2020 23,675,530 +6,292,171 +36% 31 Aug 2020 10-K 24 Nov 2021 2021 FY
Q2 2020 23,277,039 +5,893,680 +34% 31 May 2020 10-Q 07 Jul 2020 2020 Q3
Q1 2020 23,093,978 +5,713,119 +33% 29 Feb 2020 10-Q 06 Apr 2020 2020 Q2
Q4 2019 17,400,612 +22,253 +0.13% 30 Nov 2019 10-Q 09 Jan 2020 2020 Q1
Q3 2019 17,383,359 +13,484 +0.08% 31 Aug 2019 10-K 24 Nov 2020 2020 FY
Q2 2019 17,383,359 +2,914,196 +20% 31 May 2019 10-Q 10 Jul 2019 2019 Q3
Q1 2019 17,380,859 +2,974,967 +21% 28 Feb 2019 10-Q 10 Apr 2019 2019 Q2
Q4 2018 17,378,359 +3,070,469 +21% 30 Nov 2018 10-Q 14 Jan 2019 2019 Q1
Q3 2018 17,369,875 +3,701,345 +27% 31 Aug 2018 10-K 27 Nov 2019 2019 FY
Q2 2018 14,469,163 +1,149,991 +8.6% 31 May 2018 10-Q 12 Jul 2018 2018 Q3
Q1 2018 14,405,892 +1,114,280 +8.4% 28 Feb 2018 10-Q 09 Apr 2018 2018 Q2
Q4 2017 14,307,890 +1,039,664 +7.8% 30 Nov 2017 10-Q 11 Jan 2018 2018 Q1
Q3 2017 13,668,530 +485,105 +3.7% 31 Aug 2017 10-K 28 Nov 2018 2018 FY
Q2 2017 13,319,172 +188,258 +1.4% 31 May 2017 10-Q 06 Jul 2017 2017 Q3
Q1 2017 13,291,612 +181,823 +1.4% 28 Feb 2017 10-Q 05 Apr 2017 2017 Q2
Q4 2016 13,268,226 +1,665,574 +14% 30 Nov 2016 10-Q 11 Jan 2017 2017 Q1
Q3 2016 13,183,425 +1,620,348 +14% 31 Aug 2016 10-K 29 Nov 2017 2017 FY
Q2 2016 13,130,914 +2,294,354 +21% 31 May 2016 10-Q 06 Jul 2016 2016 Q3
Q1 2016 13,109,789 +2,289,596 +21% 29 Feb 2016 10-Q 06 Apr 2016 2016 Q2
Q4 2015 11,602,652 +790,181 +7.3% 30 Nov 2015 10-Q 13 Jan 2016 2016 Q1
Q3 2015 11,563,077 +1,460,522 +14% 31 Aug 2015 10-K 25 Nov 2016 2016 FY
Q2 2015 10,836,560 +880,569 +8.8% 31 May 2015 10-Q 01 Jul 2015 2015 Q3
Q1 2015 10,820,193 +1,044,026 +11% 28 Feb 2015 10-Q 03 Apr 2015 2015 Q2
Q4 2014 10,812,471 +2,864,599 +36% 30 Nov 2014 10-Q 08 Jan 2015 2015 Q1
Q3 2014 10,102,555 +2,164,683 +27% 31 Aug 2014 10-K 25 Nov 2015 2015 FY
Q2 2014 9,955,991 +2,729,568 +38% 31 May 2014 10-Q 14 Jul 2014 2014 Q3
Q1 2014 9,776,167 +2,553,531 +35% 28 Feb 2014 10-Q 10 Apr 2014 2014 Q2
Q4 2013 7,947,872 +747,872 +10% 30 Nov 2013 10-Q 14 Jan 2014 2014 Q1
Q3 2013 7,937,872 +7,870,053 +11604% 31 Aug 2013 10-K 14 Nov 2014 2014 FY
Q2 2013 7,226,423 -63,177,160 -90% 31 May 2013 10-Q 17 Jul 2013 2013 Q3
Q1 2013 7,222,636 -62,964,947 -90% 28 Feb 2013 10-Q 11 Apr 2013 2013 Q2
Q4 2012 7,200,000 -62,904,583 -90% 10 Jan 2013 10-Q 10 Apr 2014 2014 Q2
Q3 2012 67,819 -70,036,764 -100% 30 Sep 2012 10-K 12 Dec 2012 2012 FY
Q2 2012 70,403,583 31 May 2012 10-Q 12 Jul 2012 2012 Q3
Q1 2012 70,187,583 29 Feb 2012 10-Q 04 Apr 2012 2012 Q2
Q4 2011 70,104,583 30 Nov 2011 10-Q 12 Jan 2012 2012 Q1
Q3 2011 70,104,583 31 Aug 2011 10-K 12 Dec 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.